Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
Clinical trial NCT06903156 · COMPLETED
Trial details
- NCT number
- NCT06903156
- Sponsor
- Pharmasoft
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2023-09-07
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.